Open official notice

[Safety alert] Tokyo Metropolitan Government "So-called health foods: all 3 products" - Stop using

Official notice

19 Dec 2018

Last checked

27 Oct 2026

RecallScope risk estimate:HighCAA Japan

An official CAA Japan notice concerns [Safety alert] Tokyo Metropolitan Government "So-called health foods: all 3 products" - Stop using. Pharmaceutical ingredient (sibutramine) detected. ■ Results of product investigation and ingredient testing: An on-site inspection was conducted at a business in Tokyo. The following 3 products marketed as "diet supplements" were voluntarily submitted for ingredient testing, which detected the pharmaceutical ingredient "sibutramine." So-called health foods containing pharmaceutical ingredients are regarded as pharmaceuticals. Manufacturing and marketing them without approval from the Minister of Health, Labour and Welfare is prohibited under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter referred to as the "Pharmaceuticals and Medical Devices Act"). * No reports of adverse health effects caused by these products have been received to date. ■ Safety alert: As the possibility of adverse health effects from ingesting these products cannot be ruled out, anyone who has these products should stop using them immediately. If adverse health effects are suspected, promptly consult a medical institution. No pharmaceuticals containing sibutramine are approved in Japan. ※ See the website of the government agency issuing the announcement for details of the noncompliant products and information about the detected ingredient. Published 2018-12-19.

What to do now

■ Actions taken by the Tokyo Metropolitan Government: 1. The store in Tokyo (in Tachikawa City) that sold the products was instructed to stop sales and conduct a voluntary recall. 2. Information was provided to relevant organizations to raise awareness.

Official notice

2018-12-19

The hazard

Pharmaceutical ingredient (sibutramine) detected. ■ Results of product investigation and ingredient testing: An on-site inspection was conducted at a business in Tokyo. The following 3 products marketed as "diet supplements" were voluntarily submitted for ingredient testing, which detected the pharmaceutical ingredient "sibutramine." So-called health foods containing pharmaceutical ingredients are regarded as pharmaceuticals. Manufacturing and marketing them without approval from the Minister of Health, Labour and Welfare is prohibited under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter referred to as the "Pharmaceuticals and Medical Devices Act"). * No reports of adverse health effects caused by these products have been received to date. ■ Safety alert: As the possibility of adverse health effects from ingesting these products cannot be ruled out, anyone who has these products should stop using them immediately. If adverse health effects are suspected, promptly consult a medical institution. No pharmaceuticals containing sibutramine are approved in Japan. ※ See the website of the government agency issuing the announcement for details of the noncompliant products and information about the detected ingredient.

How to check if you're affected

Product identifiers are not currently available in RecallScope. Check the official notice before deciding whether your item is affected.

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

①P57 Hoodia ②LUK-SAM-RONG ③Help Body slim

Hazard

Pharmaceutical ingredient (sibutramine) detected. ■ Results of product investigation and ingredient testing: An on-site inspection was conducted at a business in Tokyo. The following 3 products marketed as "diet supplements" were voluntarily submitted for ingredient testing, which detected the pharmaceutical ingredient "sibutramine." So-called health foods containing pharmaceutical ingredients are regarded as pharmaceuticals. Manufacturing and marketing them without approval from the Minister of Health, Labour and Welfare is prohibited under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (hereinafter referred to as the "Pharmaceuticals and Medical Devices Act"). * No reports of adverse health effects caused by these products have been received to date. ■ Safety alert: As the possibility of adverse health effects from ingesting these products cannot be ruled out, anyone who has these products should stop using them immediately. If adverse health effects are suspected, promptly consult a medical institution. No pharmaceuticals containing sibutramine are approved in Japan. ※ See the website of the government agency issuing the announcement for details of the noncompliant products and information about the detected ingredient.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

JP · Japan

Affected area 1

JP · Japan

Company & contacts

Brand

【注意喚起】東京都

Manufacturer

Not provided

Phone

Not provided

Brand: 【注意喚起】東京都.

Source & status

Source

Tier

official

Category

FOOD

Official classification

消費者庁 — 使用中止

Recall details

Event id

CAA-00000021649

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 19 Dec 2018. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button